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Traumatic soft tissue injuries of the ﬁnger represent a frequent hand injury challenging hand surgeons. We report a case involving a
30-year-old man with a dorsal index ﬁnger soft tissue wound failing conservative treatment. The novel use of applied ﬁbrin membranes
and concentrated growth factors yielded complete resolution of the injury in 6 months without need for skin grafting.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Finger traumatic soft tissue defects, the most common
hand injury, represent management challenges for handhttp://dx.doi.org/10.1016/j.jdds.2015.09.002
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Production and hosting by Elseviersurgeons. When haemostasis is achieved, several factors
such as applied platelet derived growth factors, insulin-
like growth factor, and transforming growth factor beta
activate angiogenesis and ﬁbrogenesis that are involved in
cutaneous wound healing (Baum and Arpey, 2005).
Full thickness skin grafts are commonly used to cover
the ﬁngertip soft tissue defects, but with a potential for sig-
niﬁcant donor site morbidity. Previously, we reported a
series of 87 patients with ﬁnger ulcers in which topical
application of platelet gel was able to resolve clinical symp-
toms and accelerating healing time (Serra et al., 2012, 2013;
Jiritano et al., 2013; Serraino et al., 2013). We now present
a case report of successful application of ﬁbrin membranes
as a biologic wound dressing material for coverage of full
thickness digit soft tissue loss.behalf of King Saud University.
commons.org/licenses/by-nc-nd/4.0/).
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A 30-year-old man with no signiﬁcant comorbidities
presented with a post-traumatic non-healing ulcer on his
left index ﬁnger (Fig. 1). The patient experienced severe
pain (visual analogue scale, VAS 9) with poor sensation,
but no tendon involvement. Interphalangeal joint ﬂexion
and extension were maintained without deﬁcit. Blood pres-
sure was 115/75 mmHg, heart rate 82 beats/min, oxygen
pressure saturation 99%. Plain radiographs excluded the
presence of bone involvement. The subject had no history
of viral infections (i.e. HIV, HBV, HCV), diabetes or otherA 
B 
C 
Figure 1. Finger at the time of the ﬁrst presentation, before (A) and after
the cleaning (B) and after the application of ﬁbrin rich gel and the platelet
poor plasma (C).systemic diseases. Initial treatment included wound
debridement, wound dressings, systemic antibiotics (amox-
icillin and macrolides) and non-steroidal anti-inﬂammatory
drugs (NSAIDs). By post-injury day seven no wound heal-
ing was evidenced. The patient consented to a novel use of
ﬁbrin membrane treatment along with application of con-
centrated growth factors as described by Rodella et al.
(2011). Nine mL of autologous blood was drawn in sterile
Vacuette tubes (Greiner Bio-One, GmbH, Kremsmunster,
Austria) without anticoagulant solutions and immediately
centrifuged (Medifuge MF200, Silfradent srl, Forlı`, Italy)
at non-constant velocities: 3000 acceleration, 20 2700 rpm,
40 2400 rpm, 40 2700 rpm, 30 3000 rpm, and 3600 deceleration
and stop. Three blood fractions resulted: (1) the upper
platelet poor plasma (PPP) layer; (2) the middle ﬁbrin rich
gel with aggregated platelets and concentrated growth fac-
tors (CGF); (3) the lower red blood cell (RBC) layer.
The ﬁnger lesion was cleansed (Fig. 1B), cefepime was
topically applied for 30 min, after which the ﬁbrin rich
gel (fraction 2) was applied. Next the PPP (fraction 1)
(Fig. 1C) was applied and the wound was protected with
an occlusive dressing. After seven days the patient returned
for scheduled examination.
The patient was pain-free and exhibited no sign of infec-
tion (body temperature: 36.2 C). The wound treatment
described above was repeated. The wound was cleansed,
cefepime was administered topically for 30 min and autol-
ogous blood was again phlebotomized to obtain fractions 1A 
B 
Figure 2. Finger at 1-month (A) and 3-month (B) follow-up.
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Figure 3. Finger at 4-month (A) and 6-month (B) follow-up.
64 F. Romano et al. / Journal of Dermatology & Dermatologic Surgery 20 (2016) 62–64and 2 (described above) which were sequentially applied to
the wound. This procedure was used for each weekly
follow-up visit. At one-month and three-month examina-
tions signiﬁcant improvements were identiﬁed
(Fig. 2A and B). No signs of infection or inﬂammation
were present and cefepime was discontinued. During a
four-month follow-up the lesion was greatly improved
(Fig. 3A) and two months later (six months after initial
presentation, Fig. 3B), the patient achieved satisfactory
cosmetic appearance of the reconstructed digit with com-plete functional restoration. Additionally, the patient pos-
sessed intact thermal, pain and tactile sensitivity,
evaluated using cold and hot water (thermal), a needle tip
testing (pain) and cotton ball, bristle brush and strip of
paper (tactile) testing, respectively.
3. Conclusions
In conclusion the described method is a safe and eﬀec-
tive treatment for full thickness soft tissue defects of the ﬁn-
ger without skin graft donor site morbidity.
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